Vaccine Overview
Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA), Poliomyelitis (Inactivated) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) I.P.
HEXASIIL® is a 6-in-1 combination vaccine designed for infants, protecting against diphtheria, tetanus, pertussis, hepatitis B, polio (inactivated), and Haemophilus influenzae type b. Administered intramuscularly, it simplifies immunization schedules and supports early childhood immunity. It includes a primary 3-dose series starting at 6 weeks and a booster dose in the second year of life.
Drug Class: Combination Vaccines
Indication: HEXASIIL® is indicated for active immunization of infants, at or above the age of 6 weeks against Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis and invasive diseases caused by Haemophilus influenzae type b for 3 dose regimen (6, 10 & 14 Weeks) for primary vaccination and booster dose at the age of 12-24 months
PREVENTS
Vaccine Details
Applied To
Infants, Young Children
Recommended Time
Primary: 6, 10, and 14 weeks of age | Booster: 12–24 months
Administration
Route: Intramuscular Injection
Site: Antero-lateral aspect of the upper thigh
Disease
Diphtheria, Tetanus, Pertussis (Whooping Cough), Hepatitis B, Poliomyelitis, Hib (Haemophilus influenzae type b)
Manufacturer
Serum Intitute Of India
Age
- 6 weeks to 24 months
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025